| Literature DB >> 29497578 |
Carola Mullins1,2,3, Jorge Miranda1,2,3, Hugo Sandoval1,2,3, Luis Ramos-Duran1,2,3, Silvina B Tonarelli1,2,3.
Abstract
Highly active antiretroviral therapy is well-established in the treatment of human immunodeficiency virus (HIV)-positive patients. Nonadherence with therapy regimens often leads to the occurrence of opportunistic infections that further complicate treatment and challenge the treating physician. We report a young HIV-positive patient who suffered from progressive multifocal leukoencephalopathy caused by the human John Cunningham virus and showed objective clinical improvement after adding mirtazapine to the treatment regimen, an observation that is supported by the emerging literature.Entities:
Keywords: Progressive multifocal leukoencephalopathy (PML); acquired immunodeficiency syndrome (AIDS); highly active antiretroviral therapy (HAART); human immunodeficiency virus (HIV); mirtazapine
Year: 2018 PMID: 29497578 PMCID: PMC5819719
Source DB: PubMed Journal: Innov Clin Neurosci ISSN: 2158-8333